Human mesenchymal stromal cells (hMSCs) are a promising cell source for numerous regenerative medicine and cell therapy-based applications. However， MSC-based therapies have faced challenges in translation to the clinic， in part due to the lack of sufficient technologies that accurately predict MSC potency and are viable in the context of cell manufacturing. Microfluidic platforms may provide an innovative opportunity to address these challenges by enabling multiparameter analyses of small sample sizes in a high throughput and cost-effective manner， and may provide a more predictive environment in which to analyze hMSC potency. To this end， we demonstrate the feasibility of incorporating 3D culture envi... More
Human mesenchymal stromal cells (hMSCs) are a promising cell source for numerous regenerative medicine and cell therapy-based applications. However， MSC-based therapies have faced challenges in translation to the clinic， in part due to the lack of sufficient technologies that accurately predict MSC potency and are viable in the context of cell manufacturing. Microfluidic platforms may provide an innovative opportunity to address these challenges by enabling multiparameter analyses of small sample sizes in a high throughput and cost-effective manner， and may provide a more predictive environment in which to analyze hMSC potency. To this end， we demonstrate the feasibility of incorporating 3D culture environments into microfluidic platforms for analysis of hMSC secretory response to inflammatory stimuli and multi-parameter testing using cost-effective and scalable approaches. We first find that the cytokine secretion profile for hMSCs cultured within synthetic poly(ethylene glycol)-based hydrogels is significantly different compared to those cultured on glass substrates， both in growth media and following stimulation with IFN-γ and TNF-α， for cells derived from two donors. For both donors， perfusion with IFN-γ and TNF-α leads to differences in secretion of interleukin 6 (IL-6)， interleukin 8 (IL-8)， monocyte chemoattractant protein 1 (MCP-1)， macrophage colony-stimulating factor (M-CSF)， and interleukin-1 receptor antagonist (IL-1ra) between hMSCs cultured in hydrogels and those cultured on glass substrates. We then demonstrate the feasibility of analyzing the response of hMSCs to a stable concentration gradient of soluble factors such as inflammatory stimuli for potential future use in potency analyses， minimizing the amount of sample required for dose-response testing.
